Found: 143
Select item for more details and to access through your institution.
Differential inhibition of HIV-1 cell binding and HIV-1-induced syncytium formation by low molecular weight sulphated polysaccharides.
- Published in:
- 1990
- By:
- Publication type:
- journal article
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00446-4
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.939627
- By:
- Publication type:
- Article
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.788619
- By:
- Publication type:
- Article
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38892-w
- By:
- Publication type:
- Article
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0209437
- By:
- Publication type:
- Article
Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190669
- By:
- Publication type:
- Article
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e279, doi. 10.1093/infdis/jiae067
- By:
- Publication type:
- Article
Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1407, doi. 10.1093/infdis/jiac261
- By:
- Publication type:
- Article
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 3, p. 1, doi. 10.1371/journal.ppat.1006860
- By:
- Publication type:
- Article
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 2, p. 1, doi. 10.1371/journal.ppat.1006913
- By:
- Publication type:
- Article
A single gp120 residue can affect HIV-1 tropism in macaques.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 9, p. 1, doi. 10.1371/journal.ppat.1006572
- By:
- Publication type:
- Article
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 1, p. 1, doi. 10.1371/journal.ppat.1006148
- By:
- Publication type:
- Article
addendum: HIV-1 superinfection despite broad CD8<sup>+</sup> T-cell responses containing replication of the primary virus.
- Published in:
- Nature, 2003, v. 423, n. 6938, p. 461, doi. 10.1038/nature01662
- By:
- Publication type:
- Article
HIV-1 superinfection despite broad CD8<sup>+</sup> T-cell responses containing replication of the primary virus.
- Published in:
- Nature, 2002, v. 420, n. 6914, p. 434, doi. 10.1038/nature01200
- By:
- Publication type:
- Article
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
- Published in:
- Nature, 2002, v. 415, n. 6869, p. 335, doi. 10.1038/415335a
- By:
- Publication type:
- Article
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4 + T-Cells.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1662, doi. 10.3390/vaccines11111662
- By:
- Publication type:
- Article
Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 Recipients.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1904, doi. 10.3390/vaccines10111904
- By:
- Publication type:
- Article
Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 774, doi. 10.3390/vaccines9070774
- By:
- Publication type:
- Article
CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 284, doi. 10.3390/vaccines8020284
- By:
- Publication type:
- Article
Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8443, doi. 10.1038/ncomms9443
- By:
- Publication type:
- Article
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 510, p. 1, doi. 10.1126/scitranslmed.aax1880
- By:
- Publication type:
- Article
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 9, p. 1, doi. 10.1371/journal.ppat.1005864
- By:
- Publication type:
- Article
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV<sub>mac251</sub> Rectal Challenge.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 8, p. 1, doi. 10.1371/journal.ppat.1005101
- By:
- Publication type:
- Article
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 5, p. 1, doi. 10.1371/journal.ppat.1004932
- By:
- Publication type:
- Article
Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 5, p. 1, doi. 10.1371/journal.ppat.1002721
- By:
- Publication type:
- Article
Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: A possible role for the concept of metabolite Gene regulation in mammalian cells.
- Published in:
- Journal of Cellular Physiology, 1981, v. 106, n. 2, p. 283, doi. 10.1002/jcp.1041060215
- By:
- Publication type:
- Article
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.
- Published in:
- 2009
- By:
- Publication type:
- Letter
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells.
- Published in:
- Communications Biology, 2018, v. 1, n. 1, p. N.PAG, doi. 10.1038/s42003-018-0131-6
- By:
- Publication type:
- Article
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.
- Published in:
- Retrovirology, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12977-015-0210-4
- By:
- Publication type:
- Article
Aggregate complexes of HIV-1 induced by multimeric antibodies.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 2, doi. 10.1186/s12977-014-0078-8
- By:
- Publication type:
- Article
LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays.
- Published in:
- BMC Immunology, 2011, v. 12, n. 1, p. 33, doi. 10.1186/1471-2172-12-33
- By:
- Publication type:
- Article
586. Anti-HIV-1 Neutralizing Antibody Gene Delivery to Rhesus Macaques and Rodents: A Novel Vaccination Approach.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S226, doi. 10.1016/j.ymthe.2006.08.660
- By:
- Publication type:
- Article
986. In Vivo Production of Anti-HIV-1 Neutralizing Antibody from Rhesus Macaque Muscle Using a Recombinant Adeno-Associated Virus Vector
- Published in:
- 2005
- By:
- Publication type:
- Abstract
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08739-4
- By:
- Publication type:
- Article
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 8, p. 1, doi. 10.1371/journal.ppat.1008665
- By:
- Publication type:
- Article
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 6, p. 1, doi. 10.1371/journal.ppat.1008522
- By:
- Publication type:
- Article
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Cooperation between somatic mutation and germline-encoded residues enable antibody recognition of HIV-1 envelope glycans.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 12, p. 1, doi. 10.1371/journal.ppat.1008165
- By:
- Publication type:
- Article
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 12, p. 1, doi. 10.1371/journal.ppat.1008121
- By:
- Publication type:
- Article
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies.
- Published in:
- PLoS Computational Biology, 2010, v. 6, n. 10, p. 1, doi. 10.1371/journal.pcbi.1000955
- By:
- Publication type:
- Article
Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109678
- By:
- Publication type:
- Article
DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091550
- By:
- Publication type:
- Article
Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082380
- By:
- Publication type:
- Article
Detection of HIV-1 Neutralizing Antibodies in a Human CD4<sup>+</sup>/CXCR4<sup>+</sup>/CCR5<sup>+</sup> T-Lymphoblastoid Cell Assay System.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0077756
- By:
- Publication type:
- Article
Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0076104
- By:
- Publication type:
- Article